0 CHECKOUT

PRODUCT FILTERS

REGION

18
4
3
3
3

COUNTRY

PRICE

34
51
130
150

PUBLISHED

0
9
59
150

PRODUCT TYPE

136
8
4
2

Lymphoma Drugs Market Research Reports

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

Global T-Cell Lymphoma Market & Clinical Pipeline Insight

Immune system consists of various cells that impart resistance to body against foreign entities. They also prevent the development of aberrant cells in the body to maintain its normal functioning. However,...

Published:  March 2016
Price:  From

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing...

Published:  November 2014
Price:  From

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing...

Published:  August 2014
Price:  From

Follicular Lymphoma - Pipeline Review, H1 2016

Follicular Lymphoma - Pipeline Review, H1 2016 Summary ‘Follicular Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Follicular Lymphoma pipeline landscape. The report provides comprehensive...

Published:  May 2016
Price:  From

Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

Non-Hodgkin Lymphoma - Pipeline Review, H1 2016 Summary The report ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape. The...

Published:  May 2016
Price:  From

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016 Summary ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Diffuse Large B-Cell Lymphoma pipeline landscape....

Published:  May 2016
Price:  From

Burkitt Lymphoma - Pipeline Review, H1 2016

Burkitt Lymphoma - Pipeline Review, H1 2016 Summary ‘Burkitt Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Burkitt Lymphoma pipeline landscape. The report provides comprehensive...

Published:  May 2016
Price:  From

Lymphoma Treatment Drugs Markets in China

China's demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed...

Published:  May 2016
Price:  From

Lymphoma Treatment Drugs Industry Forecasts - China Focus

This study focuses on China’s Lymphoma Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities...

Published:  May 2016
Price:  From

Lymphoma Treatment Drugs Companies in China

This study focuses on China’s Lymphoma Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of...

Published:  May 2016
Price:  From

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016 Summary ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape....

Published:  April 2016
Price:  From

Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016

Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016 Summary ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016’, provides an overview of the Waldenstrom Macroglobulinemia pipeline landscape....

Published:  April 2016
Price:  From

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016 Summary ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)...

Published:  March 2016
Price:  From

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016

“ Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Anaplastic Large Cell Lymphoma (ALCL)....

Published:  March 2016
Price:  From

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016

“ Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Cutaneous T-Cell Lymphoma. The report covers the product...

Published:  March 2016
Price:  From

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016

“ Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Peripheral T-Cell Lymphomas (PTCL). The report...

Published:  March 2016
Price:  From

Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase...

Published:  March 2016
Price:  From

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales,...

Published:  March 2016
Price:  From

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Anaplastic Lymphoma...

Published:  March 2016
Price:  From
Loading Indicator

Our Clients